Archives
-
Sisomicin Activity Against Clinical Bacterial Isolates
2026-09-21
Stewart and Bodey evaluated sisomicin against 565 clinical isolates and placed its in vitro activity in direct context with gentamicin, Tobramycin, amikacin, butirosin, and kanamycin. The study found broad activity against Gram-negative bacilli, but also showed that resistance to gentamicin and Tobramycin often predicted resistance to sisomicin, highlighting the importance of comparative susceptibility testing.
-
P2Y2R-Driven Microglial Aβ42 Clearance
2026-09-20
Kim et al. identified extracellular nucleotide signaling as a mechanistic link between Aβ1–42 exposure, microglial migration, and amyloid uptake. Their study shows that P2Y2 receptor activation promotes Aβ1–42 internalization and degradation through αv integrin-, Src-, and Rac-associated signaling, providing a useful framework for interpreting microglial clearance assays.
-
SR-202: A Mechanistic Guide to PPARγ Assays
2026-09-19
SR-202 is a selective PPARγ antagonist for resolving how receptor activity shapes adipogenesis, insulin resistance, and inflammation. This guide connects metabolic assay design with macrophage-polarization evidence while defining practical limits for translation.
-
Latrunculin A in Mechanobiology Assay Design
2026-09-18
Latrunculin A is a reversible inhibitor of actin assembly that can reveal how mechanical cues become cytoskeletal responses. This article develops an assay-design framework linking G-actin sequestration to Piezo1–Ca2+–CaMKII–FAK–actin signaling in DRG axon regeneration studies.
-
Fulvestrant (ICI 182,780): ER Signaling Guide
2026-09-18
Fulvestrant, also called ICI 182,780, is a high-affinity estrogen receptor antagonist that promotes ERα degradation and suppresses ER-dependent signaling. Product data connect this mechanism with MDM2 protein degradation, apoptosis induction in breast cancer cells, and chemotherapy sensitization, while peer-reviewed immune research shows that ICI 182,780 can block estradiol-mediated effects in a hemorrhagic-shock model.
-
Dual Luciferase Assay System: Reliable Gene Readouts
2026-09-17
This scenario-based guide explains how Dual Luciferase Assay System SKU K1136 can improve normalization, media compatibility, and workflow consistency in mammalian reporter experiments. It connects practical assay design with evidence from a recent BMSC osteogenesis study and clarifies how reporter measurements should—and should not—be interpreted alongside viability data.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-09-17
A 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary cilia maintenance, and neurodevelopment. By combining a mouse model with SMPD4-deficient human iPSC-derived neural cells and ceramide rescue, the work explains how SMPD4 loss can produce microcephaly, cerebellar hypoplasia, and neural progenitor vulnerability.
-
From Astrocyte Atlas to Spatial Validation
2026-09-16
Transcriptomic atlases reveal where astrocyte states differ, but spatial assays determine how those states are organized in intact tissue. This thought-leadership guide explains how tyramide signal amplification can help translational researchers validate low-abundance astrocyte markers while preserving mechanistic and anatomical context.
-
Z-VEID-FMK: Mapping Caspase-6 Signaling
2026-09-16
Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for resolving apoptotic signaling from pyroptotic cell death. This article explains how to use it as an orthogonal pathway-mapping tool, informed by recent HOXC8–caspase-1 research in lung cancer.
-
Pexidartinib (PLX3397) in TAM Research
2026-09-15
Pexidartinib (PLX3397) provides a practical CSF1R pathway perturbation tool for dissecting macrophage survival, tumor–myeloid interactions, and treatment response. This workflow pairs target engagement and viability assays with SPP1-focused measurements, helping researchers distinguish broad macrophage modulation from direct SPP1 suppression.
-
MK0787 vs. New β-Lactams: 1982 MIC Study
2026-09-15
Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with several emerging β-lactams across resistant clinical isolates, showing especially strong activity against Pseudomonas aeruginosa, Acinetobacter, and diverse gram-negative bacilli. The study also linked low bactericidal concentrations and apparent independence from β-lactamase production, while placing cefoperazone within a historically important comparative framework for gram-negative bacterial resistance.
-
Carbenoxolone disodium: Practical Lab Guide
2026-09-14
Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in cell- and tissue-based mechanistic workflows with matched vehicle, viability, and orthogonal controls, rather than as a selective in vivo efficacy probe or clinical treatment.
-
FAISL, FAK Stability, and TNBC Metastasis
2026-09-14
A 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis, thereby promoting adhesion, survival, progression, and metastasis in triple-negative breast cancer. The work connects RNA–protein interaction biology with FAK turnover and provides preclinical evidence for targeting FAISL with reduction-responsive siRNA nanoparticles.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-13
Build a reproducible PEI-based workflow for HEK-293 transfection, transient gene expression, and recombinant protein production. Practical screening conditions, scale-up guidance, and lessons from calcium-phosphate optimization help separate true process effects from DNA, volume, and cell-health variables.
-
SW033291: 15-PGDH Inhibitor Workflow
2026-09-12
SW033291 is a small molecule 15-PGDH inhibitor for testing endogenous prostaglandin E2 elevation across biochemical, cellular, hematopoietic, and tissue-repair models. This workflow connects target engagement with practical readouts for hematopoiesis stimulation and muscle-focused tissue regeneration research while keeping translational limitations explicit.